Omalizumab May Reduce Asthma Symptoms and Steroid Requirement in EGPA Patients, Study Shows – ANCA Vasculitis News

Omalizumab May Reduce Asthma Symptoms and Steroid Requirement in EGPA Patients, Study Shows – ANCA Vasculitis News

Omalizumab May Reduce Asthma Symptoms and Steroid Requirement in EGPA Patients, Study Shows – ANCA Vasculitis News
Published on 2019-01-14